SCHEMBL25525577

SCHEMBL25525577

N#Cc1ccccc1-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cccc(-c5ccccc5)c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
TRPA1 O75762 1/20 0.38
CYP1A2 P05177 6/20 0.37
CYP3A4 P08684 5/20 0.37
ALDH1A1 P00352 4/20 0.37
HSD17B10 Q99714 4/20 0.37
CLK4 Q9HAZ1 4/20 0.37
MAPK1 P28482 2/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 4/20 0.36
CYP2C9 P11712 3/20 0.36
CYP2D6 P10635 3/20 0.36
MEN1 O00255 2/20 0.36
TSHR P16473 2/20 0.36
KMT2A Q03164 2/20 0.36
USP2 O75604 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25570469 0.99 ESR2 (0.40) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25575003 0.99 ESR2 (0.40) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25526952 0.99 ESR2 (0.40) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25573523 0.98 TRPA1 (0.39) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25575608 0.97 TRPA1 (0.39) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25570517 0.97 ESR2 (0.38) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25570216 0.97 ESR2 (0.38) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25573515 0.97 TRPA1 (0.39) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25583744 0.97 ESR2 (0.38) ESR2GABRG2GABRB3GABRA5GABRA3
SCHEMBL25570247 0.97 ESR2 (0.38) ESR2GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230309394-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 US disclosed
US-20230309394-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 US disclosed
US-20230167097-A1 HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-06-01 US disclosed
US-20230165021-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167097-A1 HETEROCYCLIC COMPOUND HAVING CYANO-SUBSTITUTION KCNH1, MCM4, MCM2 ESR2 1501/4885GABRG2 3316/4885GABRB3 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.